[an error occurred while processing this directive]

Journal of Chinese Integrative Medicine ›› 2008, Vol. 6 ›› Issue (5): 468-472.doi: 10.3736/jcim20080507

• Original Clinical Research • Previous Articles     Next Articles

Effects of Astragalous Injection on oxidative stress status in maintenance hemodialysis patients

Xiao-lu Qu1(), Qin Dai1, Ying-hui Qi1, Yong-hua Tang1, Da-hua Xu1, Zhong-hua Wu2, Xiao-xia Wang1   

  1. 1. Department of Nephrology, Shanghai Punan Hospital of Pudong New District, Shanghai 200125, China
    2. Center of Technology and Experiment, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
  • Received:2008-03-14 Online:2008-05-20 Published:2008-05-15
  • Contact: QU Xiao-lu E-mail:quxiaolu@yahoo.com.cn

RichHTML

2

PDF (PC)

75

Like

Objective: To analyze the effects of Astragalous Injection on oxidative stress and micro-inflammatory status in patients undergoing maintenance hemodialysis (MHD).
Methods: Sixty MHD patients were included and randomized into treatment group and control group, with another 10 healthy volunteers as normal control. The patients in the treatment group were treated with Astragalous Injection and the patients in the control group were treated with normal saline for 12 weeks. A spectrophotometric method was used for the measurement of plasma concentrations of oxidative parameters including advanced glycation end products (AGEs), advanced oxidation protein product (AOPP), malondialdehyde (MDA) and vitamin E (Vit E). The content of C-reactive protein (CRP) was evaluated by enzyme-linked immunosorbent assay.
Results: Compared with the normal control group, the plasma levels of AGEs, AOPP, MDA and CRP were significantly increased, while plasma level of Vit E was significantly decreased in MHD patients (P<0.01). After Astragalous Injection treatment, the plasma levels of AGEs, AOPP, MDA and CRP were decreased as compared with the control group (P<0.01), while there was no significant difference in plasma Vit E level between the treatment group and control group.
Conclusion: There exist oxidative stress and micro-inflammation in MHD patients. Astragalous Injection can ameliorate the accumulation of oxidative products and micro-inflammatory status, but it has no significant effect on plasma Vit E level.

Key words: Astragalous membranaceus , hemodialysis, oxidative stress

CLC Number: 

  • R459.52

Table 1

General data in different groups"

General data Normal control （n=10） Control （n=30） Treatment （n=30）
Sex (male/female) 6/4 18/12 12/18
Age ($\bar{x}$±s, years) 43.60±11.41 54.40±12.57 53.03±12.04
Time of therapy ($\bar{x}$±s, months) 31.17±25.59 27.23±15.80
Systolic blood pressure ($\bar{x}$±s, mmHg) 121.78±13.59 148.28±12.24 144.36±15.47
Diastolic blood pressure ($\bar{x}$±s, mmHg) 65.32±23.94 84.25±9.30 84.75±10.55
Hemoglobin ($\bar{x}$±s, g/L) 117.58±21.09 95.00±24.47 90.39±18.56
Primary disease
Chronic glomerulonephritis 0 7 10
Hypertension 0 12 6
Diabetic nephropathy 0 3 6
Urate nephropathy 0 1 1
Polycystic kidney disease 0 1 1
Lupus nephritis 0 0 1
Medical damage 0 0 1
Chronic interstitial nephritis 0 0 1
Chronic pyelonephritis 0 1 0
End-stage renal disease 0 5 3

Table 2

Changes of oxidation indexes in different group (?x ± s )"

Group n AGEs (U) AOPP (nmol/L) MDA (nmol/L) CRP (mg/L) Vit E (mg/L)
Normal control 10 1.30±0.27 67.09±25.90 3.30±1.37 2.25±1.27 13.02±3.92
Control
Pre-treatment 30 3.31±1.44** 120.76±54.59** 5.41±1.15** 7.96±6.93* 6.93±2.97**
Post-treatment 30 3.91±0.81▲ 136.27±95.44 5.02±1.13 6.64±6.83 6.50±1.46
Treatment
Pre-treatment 28 3.42±2.26** 125.35±53.51** 5.78±1.58** 6.72±6.82* 7.02±2.42**
Post-treatment 28 2.68±0.86△△▲ 87.67±41.48△▲ 4.31±1.41▲▲ 3.88±3.04▲ 7.27±2.10
[1] Liu ZQ, Hou FF, Wang L , et al. Establishment of ELISA for measuring serum advanced glycation end products(AGE) and its clinical application in patients on hemodialysis[J]. Jie Fang Jun Yi Xue Za Zhi, 2000,25(6):391-393
刘志强, 侯凡凡, 王力 , 等. ELISA 法检测人血清晚期糖基化终产物及在血液透析病人的应用[J]. 解放军医学杂志, 2000,25(6):391-393
[2] Witko-Sarsat V, Friedlander M, Nguyen Khoa T , et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure[J]. J Immunol, 1998,161(5):2524-2532
[3] Gong DH, Ji DX . Treatment status quo of end-stage renal disease patients[J]. Shen Zang Bing Yu Tou Xi Shen Yi Zhi Za Zhi, 1999,8(1):74-77
doi: 10.3969/j.issn.1006-298X.1999.01.024
龚德华, 季大玺 . 终末期肾脏病患者的透析治疗现状[J]. 肾脏病与透析肾移植杂志, 1999,8(1):74-77
doi: 10.3969/j.issn.1006-298X.1999.01.024
[4] Axelsson J, Heimbürger O, Stenvinkel P . Adipose tissue and inflammation in chronic kidney disease[J]. Contrib Nephrol., 2006,151:165-174
doi: 10.1159/000095327 pmid: 16929140
[5] Cottone S, Palermo A, Vaccaro F , et al. Oxidative stress and inflammation in long-term renal transplanted hypertensives[J]. Clin Nephrol, 2006,66(1):32-38
doi: 10.5414/CNP66032 pmid: 16878433
[6] Ben-Zvi I, Green Y, Nakhoul F , et al. Effects of diabetes mellitus, chronic renal failure and hemodialysis on serum and salivary antioxidant status[J]. Nephron Clin Pract, 2007,105(3):114-120
[7] Bergstrm J, Lindholm B, Lacson E Jr , et al. What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients?[J]. Semin Dial, 2000,13(3):163-175
[8] Kaysen GA . The microinflammatory state in uremia: causes and potential consequences[J]. J Am Soc Nephrol, 2001,12(7):1549-1557
[9] Panichi V, Migliori M, De Pietro S , et al. C-reactive protein as a marker of chronic inflammation in uremic patients[J]. Blood Purif, 2000,18(3):183-190
doi: 10.1159/000014417 pmid: 10859421
[10] Wang ZG . Oxidative stress of prevention in hemodialysis[J]. Zhongguo Xue Ye Jing Hua, 2003,2(1):5-8, 35
doi: 10.3969/j.issn.1671-4091.2003.01.003
王质刚 . 血液透析中氧化应激及其预防[J]. 中国血液净化, 2003,2(1):5-8, 35
doi: 10.3969/j.issn.1671-4091.2003.01.003
[11] Zhao YW, Wang ZG . Clinical significance of oxidative stress in hemodialysis patients[J]. Guo Wai Yi Xue Mi Niao Xi Tong Fen Ce, 2002,22(6):367-371
doi: 10.3760/cma.j.issn.1673-4416.2002.06.017
赵轶雯, 王质刚 . 血液透析患者氧化应激的临床意义[J]. 国外医学泌尿系统分册, 2002,22(6):367-371
doi: 10.3760/cma.j.issn.1673-4416.2002.06.017
[12] Witko-Sarsat V, Friedlander M, Capeillère-Blandin C , et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia[J]. Kidney Int, 1996,49(5):1304-1313.
doi: 10.1038/ki.1996.186 pmid: 8731095
[13] Miler M, Zamojska S, Fijalkowski P , et al. Assessment of malonyldialdehyde concentration as a product of lipid peroxidation and lipid metabolism in patients on chronic dialysis[J]. Pol Merkur Lekarski, 2006,20(120):664-667
[14] Shi XF, Ding F, Gu Y , et al. Markers of oxidative stress in patients undergoing maintenance hemodialysis:establishment and evaluation.[J]. Zhonghua Jian Yan Yi Xue Za Zhi, 2002,25(5):274-276.
doi: 10.3760/j:issn:1009-9158.2002.05.006
施雪枫, 丁峰, 顾勇 , 等. 维持性血液透析患者氧化应激指标的研究与评价[J]. 中华检验医学杂志, 2002,25(5):274-276.
doi: 10.3760/j:issn:1009-9158.2002.05.006
[15] Song W, Song WM, Wang RD . Traditional Chinese medical treatment of complications of hemodialysis[J]. Hebei Zhong Yi Yao Xue Bao, 2000,15(1):11-12
宋炜, 宋维明, 王润德 . 慢性肾功能衰竭血液透析并发症的中医治疗[J]. 河北中医药学报, 2000,15(1):11-12
[16] Qu XL, Zhang XS . Observation of the influence of Astragalous membranaceus on cellular immune function in patients undergoing maintenance hemodialysis[J]. Zhongguo Zhong Xi Yi Jie He Shen Bing Za Zhi, 2000,1(3):170-171
曲晓璐, 张绪生 . 黄芪对维持性血液透析患者细胞免疫影响的观察[J]. 中国中西医结合肾病杂志, 2000,1(3):170-171
[17] Zuo JY, Wang XC, Zhu XL . The influence of Astragalous membranaceus on SOD and LPD in patients with chronic renal failure[J]. Yi Xue Lin Chuang Yan Jiu, 2003,20(2):158-159
doi: 10.3969/j.issn.1671-7171.2003.02.037
左菊英, 王湘川, 朱新林 . 黄芪对慢性肾衰患者SOD及LPD的影响[J]. 医学临床研究, 2003,20(2):158-159
doi: 10.3969/j.issn.1671-7171.2003.02.037
[18] Mo ZY, Liang D, Si TY , et al. Effect of Astragalous on oxidative stress status in primary nephrotic syndrome[J]. Zhongguo Zhong Xi Yi Jie He Shen Bing Za Zhi, 2004,5(4):209-211
doi: 10.3969/j.issn.1009-587X.2004.04.008
莫湛宇, 梁东, 司徒玉 , 等. 黄芪对肾病综合征患者氧化应激影响的研究[J]. 中国中西医结合肾病杂志, 2004,5(4):209-211
doi: 10.3969/j.issn.1009-587X.2004.04.008
[19] Shen J, Xu HQ, Liu H , et al. Influence of Astragalous injection on glomerular mesangial cells cultured with AGEs[J]. Zhong Cheng Yao, 2006,28(8):1170-1174
doi: 10.3969/j.issn.1001-1528.2006.08.026
沈健, 许惠琴, 刘洪 , 等. 黄芪注射液对AGEs培养肾小球系膜细胞的影响[J]. 中成药, 2006,28(8):1170-1174
doi: 10.3969/j.issn.1001-1528.2006.08.026
[20] Zhao DX, Lin QZ, Bao K , et al. Effect of Yiqi Gushen Dialysate on biocompatibility of dialysis-membrane[J]. Zhongguo Zhong Xi Yi Jie He Shen Bing Za Zhi, 2004,5(11):648-649
doi: 10.3969/j.issn.1009-587X.2004.11.011
赵代鑫, 林启展, 包崑 , 等. 益气固肾液对透析膜生物相溶性的影响[J]. 中国中西医结合肾病杂志, 2004,5(11):648-649
doi: 10.3969/j.issn.1009-587X.2004.11.011
[1] Gao Shan, Wang Xing-hui, Huang Ling-ling, Yu Ting-ting, Du Su-ming, Guo Yan-wei, Jia Yuan, Wang Jian. Effects of a compound Chinese medicine Xinji’erkang on isoproterenol-induced ventricular remodeling in mice. Journal of Chinese Integrative Medicine, 2012, 10(3): 330-336.
[2] Mao Zhi-min, Song Hai-yan, Yang Li-li, Liu Tao, Li Dong-fei, Zheng Pei-yong, Liu Ping, Ji Guang. Effects of the mixture of Swertia pseudochinensis Hara and Silybum marianum Gaertn extracts on CCl4-induced liver injury in rats with non-alcoholic fatty liver disease. Journal of Chinese Integrative Medicine, 2012, 10(2): 193-199.
[3] Kaulaskar Shyam, Bhutada Pravinkumar, Rahigude Anand, Jain Dilpesh, Harle Uday. Effects of naringenin on allodynia and hyperalgesia in rats with chronic constriction injury-induced neuropathic pain. Journal of Chinese Integrative Medicine, 2012, 10(12): 1482-1489.
[4] Xin Liu, Wei Min . Protective effects of astragaloside against ultraviolet A-induced photoaging in human fibroblasts. Journal of Chinese Integrative Medicine, 2011, 9(3): 328-332.
[5] Oluwole Busayo Akinola, Gabriel Olaiya Omotoso, Oluwafunmike Sharon Akinola, Olufunke Olubusola Dosumu, Esther Tomi Adewoye. Effects of combined leaf extract of Vernonia amygdalina and Azadirachta indica on hepatic morphology and hepatotoxicity markers in streptozotocin-induced diabetic rats. Journal of Chinese Integrative Medicine, 2011, 9(12): 1373-1379.
[6] Mei-na Ye, Hong-feng Chen, Rui-juan Zhou, Ming-juan Liao. Effects of Astragalus polysaccharide on proliferation and Akt phosphorylation of the basal-like breast cancer cell line. Journal of Chinese Integrative Medicine, 2011, 9(12): 1339-1346.
[7] Nilesh Kumar Jain, Santram Lodhi, Avijeet Jain, Alok Nahata, Abhay K. Singhai. Effects of Phyllanthus acidus (L.) Skeels fruit on carbon tetrachloride-induced acute oxidative damage in livers of rats and mice. Journal of Chinese Integrative Medicine, 2011, 9(1): 49-56.
[8] Hua Tan, Xiao-ping Huang, Chang-qing Deng. Effects of astragalosides and Panax notoginseng saponins combination on oxidative stress of cerebral ischemic reperfusion injury in mice. Journal of Chinese Integrative Medicine, 2010, 8(5): 448-452.
[9] Yan-yan Li, Yong-hui Wang, Yong-gang Zhang, Yun Bai, Ran Zhou. Effects of Huangqi Guizhi Wuwu Decoction given by different administration methods on rats with frostbite and the mechanism. Journal of Chinese Integrative Medicine, 2010, 8(2): 181-185.
[10] Wen-xiang Zhou, Wen-bin Zheng, Xiao-mei Huang, Ying Zhang, Xiang-zhi Nie, Hong-bing Li, Da He, Lan-qian Xie. Effects of oxymatrine on microinflammatory state in patients undergoing continuous hemodialysis: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2009, 7(8): 736-740.
[11] Ying Deng , Hong-feng Chen. Effects of Astragalus injection and its ingredients on proliferation and Akt phosphorylation of breast cancer cell lines. Journal of Chinese Integrative Medicine, 2009, 7(12): 1174-1180.
[12] Shan Mou, Zhao-hui Ni, Qing-yi Zhang. Expression of c-met in human kidney fibroblasts induced by high glucose in vitro and the regulation of Radix Astragali. Journal of Chinese Integrative Medicine, 2008, 6(5): 482-487.
[13] Gui-hua Xu, Li Yuan, Yan Li, Ping Xie, Jin-yuan Zhao, Yong-hua Chen. Clinical observation of Astragalus Injection in treatment of renal injury in patients with primary hypertension. Journal of Chinese Integrative Medicine, 2008, 6(5): 530-532.
[14] Mei-na Ye, Hong-feng Chen. Effects of Astragalus injection on proliferation of basal-like breast cancer cell line MDA-MB-468. Journal of Chinese Integrative Medicine, 2008, 6(4): 399-403.
[15] Ru-jiang Li, Shu-dong Qiu, Hong-xia Chen, Li-rong Wang. Immunomodulatory effects of Astragalus polysaccharide in diabetic mice. Journal of Chinese Integrative Medicine, 2008, 6(2): 166-170.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239
[an error occurred while processing this directive]